This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Jiuzhitang Co., Ltd., Mudanjiang Youbo Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yanming Chen: Innovator in Antithrombotic Research
Introduction
Yanming Chen is a notable inventor based in Mudanjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit coagulation factors. His work is crucial in the ongoing fight against thrombotic diseases.
Latest Patents
Yanming Chen holds a patent for an "Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof." This patent describes a purified oligosaccharide compound that exhibits antithrombotic activity. The invention includes a preparation method for the compound, a pharmaceutical composition containing it, and its applications as an intrinsic factor X-enzyme inhibitor in drug development aimed at preventing and treating thrombotic diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Yanming Chen has worked with prominent companies in the pharmaceutical industry. Notable among these are Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical treatments.
Collaborations
Yanming Chen has collaborated with several professionals in his field, including Jikai Liu and Na Gao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Yanming Chen's contributions to antithrombotic research through his innovative patent and collaborations with industry professionals highlight his importance in the pharmaceutical field. His work continues to pave the way for advancements in the treatment of thrombotic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile